Methadone adverse reaction presenting with large increase in plasma methadone binding: a case series

Area of Science:

• Pharmacology
• Clinical Pharmacology
• Drug Metabolism and Interactions

Background:

• Methadone is an increasingly used analgesic with unpredictable pharmacokinetics and side effects.
• Mechanisms for methadone's unpredictable effects and drug interactions are often unclear.
• This study reports a novel association between methadone overexposure and increased plasma protein binding.

Purpose of the Study:

• To investigate the pharmacokinetic changes in methadone response during co-administration with letrozole.
• To identify potential mechanisms for the observed variability in patient response to methadone.
• To explore the role of plasma protein binding in methadone drug interactions.

Main Methods:

• Case study of two patients receiving methadone and letrozole.
• Pharmacokinetic analysis of methadone in affected and unaffected patients.
• Measurement of plasma protein binding and plasma concentrations of methadone.

Main Results:

• One patient experienced methadone overexposure symptoms with a 4-8 fold increase in plasma concentrations after letrozole.
• Affected patient showed a 3.7-fold decrease in unbound methadone and a 4-fold decrease in volume of distribution.
• No significant changes in methadone metabolism or renal elimination were observed.

Conclusions:

• Increased plasma protein binding significantly reduces methadone's volume of distribution, leading to higher plasma concentrations.
• Plasma protein binding is a crucial factor explaining methadone's unpredictable pharmacokinetics.
• Altered volume of distribution due to plasma binding can cause clinically significant drug interactions.